PROTAC Library

Loading...
E3 Ligase
Target
Molecular Weight
to
Your selection
  • Your selection
Structure Catalog Product Name CAS E3 Ligase Target Inquiry
(Z)-N-(2-((8-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)octyl)(ethyl)amino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide BPL-201293 (Z)-N-(2-((8-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)octyl)(ethyl)amino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide 2227367-49-7

CRBN

c-KIT

Inquiry

Molecular Weight: 753.88

Molecular Formula: C41H48FN7O6

Boiling Point: 949.9±65.0°C at 760 Torr

Density: 1.324±0.06 g/cm3

Description: It is a phenotypically relevant off-target of heterobifunctional phthalimide degrader.

(Z)-N-(8-(4-(((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)methyl)benzamido)octyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide BPL-201294 (Z)-N-(8-(4-(((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)methyl)benzamido)octyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide 2222635-95-0

CRBN

c-KIT

Inquiry

Molecular Weight: 815.89

Molecular Formula: C45H46FN7O7

Boiling Point: 1042.8±65.0°C at 760 Torr

Density: 1.366±0.06 g/cm3

Description: It is a phenotypically relevant off-target of heterobifunctional phthalimide degrader.

(Z)-2-(2,6-Dioxopiperidin-3-yl)-N-(6-(5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamido)hexyl)-1,3-dioxoisoindoline-5-carboxamide BPL-201295 (Z)-2-(2,6-Dioxopiperidin-3-yl)-N-(6-(5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamido)hexyl)-1,3-dioxoisoindoline-5-carboxamide 2222635-96-1

CRBN

c-KIT

Inquiry

Molecular Weight: 682.71

Molecular Formula: C36H35FN6O7

Boiling Point: 949.6±65.0°C at 760 Torr

Density: 1.411±0.06 g/cm3

Description: It is a phenotypically relevant off-target of heterobifunctional phthalimide degrader.

(Z)-2-(2,6-Dioxopiperidin-3-yl)-N-(8-(5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamido)octyl)-1,3-dioxoisoindoline-5-carboxamide BPL-201296 (Z)-2-(2,6-Dioxopiperidin-3-yl)-N-(8-(5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamido)octyl)-1,3-dioxoisoindoline-5-carboxamide 2222635-97-2

CRBN

c-KIT

Inquiry

Molecular Weight: 710.76

Molecular Formula: C38H39FN6O7

Boiling Point: 955.6±65.0°C at 760 Torr

Density: 1.375±0.06 g/cm3

Description: It is a phenotypically relevant off-target of heterobifunctional phthalimide degrader.

(Z)-N-(5-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)pentyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide BPL-201297 (Z)-N-(5-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)pentyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide 2222635-98-3

CRBN

c-KIT

Inquiry

Molecular Weight: 640.67

Molecular Formula: C34H33FN6O6

Boiling Point: 923.9±65.0°C at 760 Torr

Density: 1.435±0.06 g/cm3

Description: It is a phenotypically relevant off-target of heterobifunctional phthalimide degrader.

MI-389 BPL-201298 MI-389 2222635-99-4

CRBN

c-KIT

Inquiry

Molecular Weight: 654.69

Molecular Formula: C35H35FN6O6

Boiling Point: 926.5±65.0°C at 760 Torr

Density: 1.414±0.06 g/cm3

Description: It is a phenotypically relevant off-target of heterobifunctional phthalimide degrader.

(Z)-N-(8-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)octyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide BPL-201299 (Z)-N-(8-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)octyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide 2222636-00-0

CRBN

c-KIT

Inquiry

Molecular Weight: 682.75

Molecular Formula: C37H39FN6O6

Boiling Point: 932.8±65.0°C at 760 Torr

Density: 1.376±0.06 g/cm3

Description: It is a phenotypically relevant off-target of heterobifunctional phthalimide degrader.

(Z)-N-(8-(4-(((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)methyl)benzamido)octyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide BPL-201300 (Z)-N-(8-(4-(((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)methyl)benzamido)octyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide 2222636-01-1

CRBN

c-KIT

Inquiry

Molecular Weight: 815.89

Molecular Formula: C45H46FN7O7

Boiling Point: 1048.2±65.0°C at 760 Torr

Density: 1.366±0.06 g/cm3

Description: It is a phenotypically relevant off-target of heterobifunctional phthalimide degrader.

(Z)-N-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)ethoxy)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide BPL-201301 (Z)-N-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)ethoxy)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide 2222636-02-2

CRBN

c-KIT

Inquiry

Molecular Weight: 642.64

Molecular Formula: C33H31FN6O7

Boiling Point: 932.0±65.0°C at 760 Torr

Density: 1.472±0.06 g/cm3

Description: It is a phenotypically relevant off-target of heterobifunctional phthalimide degrader.

(Z)-N-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)ethoxy)ethoxy)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide BPL-201302 (Z)-N-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)ethoxy)ethoxy)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide 2222636-03-3

CRBN

c-KIT

Inquiry

Molecular Weight: 686.69

Molecular Formula: C35H35FN6O8

Boiling Point: 950.3±65.0°C at 760 Torr

Density: 1.443±0.06 g/cm3

Description: It is a phenotypically relevant off-target of heterobifunctional phthalimide degrader.

YX-2-79 BPL-201303 YX-2-79 2676958-51-1

VHL

CDK4
CDK6

Inquiry

Molecular Weight: 1159.39

Molecular Formula: C58H74N14O10S

Density: 1.42±0.1 g/cm3

Description: It is a CDK4/6-targeted PROTAC that selectively inhibits the growth of ph-positive ALL cells through kinase-dependent and independent effects.

AC-1-027 BPL-201304 AC-1-027 2417408-53-6

CRBN

CDK4
CDK6

Inquiry

Molecular Weight: 875.94

Molecular Formula: C44H49N11O9

Density: 1.427±0.06 g/cm3

Description: It is a CDK4/6-targeted PROTAC that selectively inhibits the growth of ph-positive ALL cells through kinase-dependent and independent effects.

AC-1-112 BPL-201305 AC-1-112 2417408-59-2

CRBN

CDK4
CDK6

Inquiry

Molecular Weight: 994.08

Molecular Formula: C49H59N11O12

Density: 1.387±0.06 g/cm3

Description: It is a CDK4/6-targeted PROTAC that selectively inhibits the growth of ph-positive ALL cells through kinase-dependent and independent effects.

YX-2-107 BPL-201306 YX-2-107 2417408-46-7

CRBN

CDK4
CDK6

Inquiry

Molecular Weight: 889.97

Molecular Formula: C45H51N11O9

Density: 1.409±0.06 g/cm3

Description: It is a CDK4/6-targeted PROTAC that selectively inhibits the growth of ph-positive ALL cells through kinase-dependent and independent effects.

YX-2-233 BPL-201307 YX-2-233 2417408-49-0

MDM2

CDK4
CDK6

Inquiry

Molecular Weight: 1209.34

Molecular Formula: C65H79Cl2N13O6

Density: 1.32±0.1 g/cm3

Description: It is a CDK4/6-targeted PROTAC that selectively inhibits the growth of ph-positive ALL cells through kinase-dependent and independent effects.

AC-2-011 BPL-201308 AC-2-011 2417408-60-5

CRBN

CDK4
CDK6

Inquiry

Molecular Weight: 835.87

Molecular Formula: C42H43F2N11O6

Density: 1.51±0.1 g/cm3

Description: It is a CDK4/6-targeted PROTAC that selectively inhibits the growth of ph-positive ALL cells through kinase-dependent and independent effects.

(2S,4R)-1-((S)-2-(2-(3-((5-(4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-yl)phenoxy)pentyl)oxy)propoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide BPL-201309 (2S,4R)-1-((S)-2-(2-(3-((5-(4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-yl)phenoxy)pentyl)oxy)propoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide

VHL

AR

Inquiry

Molecular Weight: 1004.14

Molecular Formula: C51H60F3N7O9S

Description: It is a PROTAC-androgen receptor degrader used in the treatment of prostate cancer and Kennedy's disease.

(4R)-N-[2-[3-[2-[4-[4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]phenyl]-1-piperidinyl]ethoxy]propoxy]acetyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-L-prolinamide BPL-201310 (4R)-N-[2-[3-[2-[4-[4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]phenyl]-1-piperidinyl]ethoxy]propoxy]acetyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-L-prolinamide 1973403-05-2

VHL

AR

Inquiry

Molecular Weight: 1045.26

Molecular Formula: C53H63F3N8O7S2

Density: 1.37±0.1 g/cm3

Description: It is a PROTAC-androgen receptor degrader used in the treatment of prostate cancer and Kennedy's disease.

(4R)-N-[2-[[5-[4-[[[trans-3-(3-Chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl]amino]carbonyl]phenoxy]pentyl]oxy]acetyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(5-thiazolyl)phenyl]methyl]-L-prolinamide BPL-201311 (4R)-N-[2-[[5-[4-[[[trans-3-(3-Chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl]amino]carbonyl]phenoxy]pentyl]oxy]acetyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(5-thiazolyl)phenyl]methyl]-L-prolinamide 1973403-75-6

VHL

AR

Inquiry

Molecular Weight: 941.59

Molecular Formula: C50H61ClN6O8S

Boiling Point: 1118.9±65.0°C at 760 Torr

Density: 1.31±0.1 g/cm3

Description: It is a PROTAC-androgen receptor degrader used in the treatment of prostate cancer and Kennedy's disease.

(4R)-N-[2-[[5-[[4-[[[trans-3-(3-Chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl]amino]carbonyl]phenyl]amino]pentyl]oxy]acetyl]-3-methyl-L-valyl-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-L-prolinamide BPL-201312 (4R)-N-[2-[[5-[[4-[[[trans-3-(3-Chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl]amino]carbonyl]phenyl]amino]pentyl]oxy]acetyl]-3-methyl-L-valyl-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-L-prolinamide 1973404-08-8

VHL

AR

Inquiry

Molecular Weight: 968.66

Molecular Formula: C52H66ClN7O7S

Boiling Point: 1119.3±65.0°C at 760 Torr

Density: 1.28±0.1 g/cm3

Description: It is a PROTAC-androgen receptor degrader used in the treatment of prostate cancer and Kennedy's disease.

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Inquiry Basket